MedPath

Brillant Blue Versus Indocyanine Green for Macular Hole Surgery

Not Applicable
Completed
Conditions
Idiopathic Macular Holes
Registration Number
NCT00757471
Lead Sponsor
The Ludwig Boltzmann Institute of Retinology and Biomicroscopic Laser Surgery
Brief Summary

Macular Hole Surgery with two different Dyes

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
60
Inclusion Criteria
  • Idiopathic stage 3 and 4 macular holes
  • Stage 2 macular holes, followed up for at least 6 months
  • Pseudophakic and phakic eyes
  • Age over 60 years
Exclusion Criteria
  • Traumatic macular holes
  • Secondary macular holes
  • Severe ocular diseases

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Macular Hole Closure Rate12 Months
Secondary Outcome Measures
NameTimeMethod
Visual Acuity Microperimetry Optical Coherence Tomography12 Months

Trial Locations

Locations (1)

The Ludwig Boltzmann Institute of Retinology and Biomicroscopic Laser surgery

🇦🇹

Vienna, Austria

The Ludwig Boltzmann Institute of Retinology and Biomicroscopic Laser surgery
🇦🇹Vienna, Austria

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.